We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

An image depicting single-cell sequencing.
Industry Insight

Advances in Mass Spectrometry Drive Immunopeptidomics

At the 71st Annual Society for Mass Spectrometry (ASMS) meeting, Technology Networks had the pleasure of speaking with Rohan Thakur, president of Life Sciences Mass Spectrometry at Bruker Daltonics. We discussed the new product launches from Bruker and focused specifically on the applications of the company’s newest mass spectrometer, the timsTOF Ultra, for immunopeptidomics.
10th birthday candle and confetti.
Industry Insight

A Decade of DIA and Key Milestones: The 10-Year Anniversary of SWATH DIA

The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.
Connecting hexagons each with a symbol relating to health, medicine and data.
Industry Insight

The Impact of Proteomics on Precision Oncology

To find out more about how proteomics is providing new insights into cancer dynamics and resistance mechanisms, we spoke to Dr. Ofer Sharon, CEO of OncoHost, a precision diagnostics company.
Computer-generated image of a DNA double helix.
Industry Insight

Advances in DNA Methylation Profiling and Biomarker Discovery

Technology Networks spoke with Anjali Pradhan, senior vice president of product management at Mission Bio, to discuss a new application for DNA methylation analysis, and its potential in uncovering new biological insights and biomarkers that may guide the future of cancer research.
What Do Advances in Structural Proteomics Mean for Drug Development? content piece image
Industry Insight

What Do Advances in Structural Proteomics Mean for Drug Development?

This article will cover innovations in structural proteomics, a new way to identify drug targets across the proteome, a new method to dissect drug–protein interactions and the future of structure-based drug design.
Fluid-filled LC-MS bottles.
Industry Insight

A New Era of MS-Based Proteomics To Advance Human Wellness

Technology Networks spoke to Katherine Tran from SCIEX about the latest advances in data-independent acquisition mass spectrometry and how it can be used to further our understanding of the proteome in health and disease.
Futuristic representation of human genomics.
Industry Insight

Probing the Biomarker Landscape of Human Disease

To find out more about the importance of improving biomarker discovery and how next-generation mass spectrometry-based systems can help to fill the current gap in biomarker technologies, Technology Networks spoke with Dr. Mo Jain.
Tower Bridge, London.
Industry Insight

The UK Is Facing a Science and Tech Exodus

In this opinion piece, Liz Sparrow discusses the real risk of the UK losing its science and technology communities as they face a series of challenges that are threatening their growth.
Representation of DNA and protein molecules.
Industry Insight

Using Library-Based Approaches To Increase Depth and Accuracy of Proteome Profiling

This article discusses how library-based approaches in quantitative proteomics can increase the sensitivity and accuracy of such detection systems.
The Road to a Sustainable Precision Health Ecosystem in Taiwan content piece image
Industry Insight

The Road to a Sustainable Precision Health Ecosystem in Taiwan

To find out more about the Taiwan Precision Medicine Initiative and its aim to implement a sustainable precision health ecosystem in Taiwan, we spoke to Dr. Pui-Yan Kwok, leader of the initiative.
Advertisement